Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:XLRN
Delisted

Acceleron Pharma Inc. Stock Price (Quote)

$178.75
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $178.75 $178.75 Friday, 27th May 2022 XLRN stock ended at $178.75. During the day the stock fluctuated 0% from a day low at $178.75 to a day high of $178.75.
90 days $178.75 $178.75
52 weeks $113.49 $189.99

Historical Acceleron Pharma Inc. prices

Date Open High Low Close Volume
Sep 30, 2016 $36.76 $37.34 $36.01 $36.19 379 400
Sep 29, 2016 $39.35 $39.35 $36.29 $36.41 530 400
Sep 28, 2016 $40.52 $40.52 $38.77 $39.58 307 100
Sep 27, 2016 $39.11 $40.70 $38.91 $40.47 259 300
Sep 26, 2016 $39.21 $39.53 $38.64 $39.15 242 900
Sep 23, 2016 $40.00 $40.33 $38.99 $39.50 274 900
Sep 22, 2016 $38.42 $40.38 $38.12 $40.00 439 800
Sep 21, 2016 $37.77 $38.40 $36.98 $38.12 385 000
Sep 20, 2016 $36.85 $37.67 $36.33 $37.48 381 400
Sep 19, 2016 $34.84 $37.20 $34.45 $36.50 396 000
Sep 16, 2016 $33.40 $34.60 $32.45 $34.51 415 400
Sep 15, 2016 $34.22 $34.42 $32.72 $33.51 288 300
Sep 14, 2016 $33.23 $34.58 $33.23 $34.41 329 600
Sep 13, 2016 $32.64 $33.46 $31.52 $33.16 320 300
Sep 12, 2016 $31.24 $32.66 $31.24 $32.57 260 000
Sep 09, 2016 $32.09 $32.46 $30.97 $31.40 451 000
Sep 08, 2016 $31.65 $32.48 $30.29 $32.32 131 900
Sep 07, 2016 $32.00 $32.20 $31.18 $31.68 275 000
Sep 06, 2016 $31.06 $32.65 $30.82 $32.02 275 100
Sep 02, 2016 $30.38 $31.62 $30.25 $30.84 131 700
Sep 01, 2016 $30.03 $30.80 $29.88 $30.25 135 700
Aug 31, 2016 $30.15 $30.77 $29.26 $30.01 279 400
Aug 30, 2016 $30.26 $30.84 $30.11 $30.32 85 000
Aug 29, 2016 $30.33 $30.51 $29.62 $30.28 123 900
Aug 26, 2016 $29.78 $30.55 $29.40 $30.21 146 400
Click to get the best stock tips daily for free!

About Acceleron Pharma Inc.

Acceleron Pharma. Acceleron Pharma Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of protein therapeutics for cancer and rare diseases. It is developing sotatercept to treat patients with chronic kidney disease, including mineral-bone disorder, vascular calcification, and anemia; and luspatercept to treat anemia and associated complications in patients with myelodysplastic syndromes and beta-thalassem... XLRN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT